iKang Healthcare (KANG) Reports Q4 EPS of $0.48

iKang Healthcare (NASDAQ: KANG) reported Q4 EPS of $0.48, versus $0.35 reported last year. Revenue for the quarter came in at $60.2 million, versus $52.84 million reported last year.

GUIDANCE FOR FISCAL YEAR 2017 ENDING MARCH 31, 2018

For the Fiscal Year 2017 ending March 31, 2018, the Company expects its net revenue to be between RMB3.52 billion and RMB3.72 billion, representing a year-on-year increase between 22% and 27%. The Company also expects that 12-15 new medical centers will start commercial operation in Fiscal Year 2017.

This guidance is based on the current market conditions and reflects the Company's current and preliminary estimates of market and operating conditions and customer demand, which are all subject to change

For earnings history and earnings-related data on iKang Healthcare (KANG) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c